Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.24 Delayed Data As of May 25 |  +0.06 / +2.74%Today’s Change | 1.93 Today|||52-Week Range 6.50 | -42.42% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 24.9M | 1.5M | 10.7M | 5.9M | |
| Depreciation And Amortization | 589.0K | 1.1M | 2.0M | 2.2M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 61.2M | 68.7M | 78.8M | 74.0M | ||
| Research And Development | 47.3M | 55.3M | 62.7M | 58.0M | ||
| Total Operating Expenses | 61.8M | 69.8M | 80.8M | 76.1M | ||
| Non-Operating Expenses | Operating Income | -37.0M | -68.3M | -70.1M | -70.2M | |
| Extraordinary Credit | 3.3M | 530.0K | 0.00 | 32.2M | ||
| Extraordinary Charge | -66.1M | -424.9M | -42.2M | -19.6M | ||
| Pre-Tax Equity Earnings | 0.00 | 0.00 | 0.00 | -5.6M | ||
| Interest Expense On Debt | 0.00 | -- | 261.0K | 226.0K | ||
| Other Expenses | 21.8M | 2.1M | 2.3M | -1.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -77.3M | -489.2M | -108.7M | -61.4M | |
| Income Taxes | -16.2M | -105.0M | -24.3M | -4.3M | ||
| Preferred Dividend | 0.00 | 0.00 | -911.0K | -10.1M | ||
| Net Income | -61.1M | -384.2M | -84.4M | -57.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 45.5M | 53.1M | 54.7M | 55.3M | |
| Shares To Calculate EPS Diluted | 45.5M | 53.1M | 54.7M | 55.3M | ||
| Earnings Per Share | EPS | -$1.34 | -$7.24 | -$1.56 | -$1.21 | |
| EPS Diluted | -$1.34 | -$7.24 | -$1.56 | -$1.21 | ||
